Dr. Chengfeng Bi is an Assistant Professor of Hematology and Oncology at the University of Nebraska Medical Center. His research centers on the molecular pathogenesis of blood cancers and the development of novel therapeutic strategies. With over a decade of experience in lymphoma research, Dr. Bi has extensive expertise in translational studies and a sustained commitment to advancing therapeutic innovation in hematologic malignancies. He serves as the Principal Investigator of the North American Mantle Cell Lymphoma Project (NAMCLP), a collaborative network of 23 institutions across North America dedicated to improving the clinical management of Mantle Cell Lymphoma (MCL) through large-scale, multi-institutional research and the translation of biological discoveries into improved patient outcomes.
Chengfeng Bi MD, PhD
University of Nebraska Medical Center
Omaha, Nebraska
United States
Project Title
SHP-1 Activation by Sorafenib Derivatives as a Novel Therapeutic Strategy for Mantle Cell Lymphoma
Program
Translational Research Program